Skip to main content
OpenTrials

Clinical trial condition

Hematological Malignancies

Explore clinical trials studying Hematological Malignancies. Study availability and eligibility vary by location and protocol.

99 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Hematological Malignancies trial results

Recruiting

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT04634552

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 78 locations
View Trial Details
Recruiting

Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies

NCT06652633

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Antwerp University Hospital Edegem, Belgium
  • Universitair Ziekenhuis Leuven Leuven, Belgium
  • Centre Hospitalier Universitaire (CHU) De Liège Liège, Belgium
View Trial Details
Recruiting

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

NCT06224855

Conditions
Advanced Solid Tumors, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
View Trial Details
Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592

Conditions
B-cell Malignancy, Low-grade, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute at St. Elizabeth's Brighton, Massachusetts, United States
  • Dana Farber Cancer Institute at Merrimack Valley Methuen, Massachusetts, United States
  • Dana Farber Cancer Institute at Milford Regional Medical Center Milford, Massachusetts, United States
View Trial Details
Recruiting

A Clinical Study of HMPL-506 in Patients With Hematological Malignancies

NCT06387082

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • Xiangya Hospital of Central South University Changsha, China
  • First Affiliated Hospital of Chongqing Medical University Chongqing, China
  • Fujian Medical University Union Hospital Fuzhou, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
View all 16 locations
View Trial Details
Recruiting

The Study of ICP-248 in Patients With Mature B-cell Malignancies

NCT05728658

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View all 22 locations
View Trial Details

Related conditions